SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (1183)10/25/1999 6:54:00 PM
From: Mike M  Read Replies (1) of 5582
 
. Do you think PFE would hype a new drug before they had conclusive clinical evidence that it worked?


Hank, I don't think that is a fair question. GUMM does have conclusive evidence. I am absolutely certain of that. They have the results of the "wild virus study", the first clinical. You know that they are unable to release those results if they have any hope of publication. I think it fair to say that NEJM won't publish but I believe someone will. GUMM is further going above and beyond by conducting a 2d study, "innoculation induced virus".

PFE is a great company. I believe that if PFE were to own Zicam they too would operate within the legal limits of the law and that they would do exactly what Gel Tech is doing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext